Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Genpact Limited (G): Are Hedge Funds Right About This Stock?

Page 1 of 2

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn’t mean that they don’t have occasional colossal losses; they do (like Ackman’s recent Valeant losses). However, it is still good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards Genpact Limited (NYSE:G).

Genpact Limited (NYSE:G) has experienced a decrease in support from the world’s most elite money managers of late. G was in 17 hedge funds’ portfolios at the end of the third quarter of 2015. There were 22 hedge funds in our database with G positions at the end of the previous quarter. At the end of this article we will also compare G to other stocks including ADT Corp (NYSE:ADT), FireEye Inc (NASDAQ:FEYE), and Edgewell Personal Care Company (NYSE:EPC) to get a better sense of its popularity.

Follow Genpact Ltd (TSE:G)
Trade (TSE:G) Now!

With all of this in mind, we’re going to check out the key action encompassing Genpact Limited (NYSE:G).

What does the smart money think about Genpact Limited (NYSE:G)?

At the end of the third quarter, a total of 17 of the hedge funds tracked by Insider Monkey were long this stock, a change of -23% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a few noteworthy hedge fund managers who were increasing their stakes significantly (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Eminence Capital, managed by Ricky Sandler, holds the largest position in Genpact Limited (NYSE:G). Eminence Capital has a $189.4 million position in the stock, comprising 2.9% of its 13F portfolio. Coming in second is D E Shaw, holding a $51.2 million position; 0.1% of its 13F portfolio is allocated to the company. Other members of the smart money that are bullish consist of Richard S. Pzena’s Pzena Investment Management, Cliff Asness’ AQR Capital Management and Ken Fisher’s Fisher Asset Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!